Precision Therapeutics Inc (AIPT) - Medical Equipment - Deals and Alliances Profile
- GDME323892D
- Pages: 57
- October 2018
- Total Views:1126
- Region : North America
- GlobalData
- Equity Research Report
Details
Summary
Precision Therapeutics Inc (Precision Therapeutics), a joint venture between Skyline Medical and Helomics, is a medical device company. The company's business divisions include artificial intelligence to personalized medicine and drug discovery; and system for automated, direct-to-drain medical fluid disposal. Precision Therapeutics offers the STREAMWAY Fluid Waste Management system that removes surgical waste fluid from the patient using standard surgical tubing; and disposables. The company works with pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for cancer patients. It offers personalized medicine solutions for patients, clinicians and clients. Precision Therapeutics is headquartered in Eagan, Minnesota, the US.
Precision Therapeutics Inc (AIPT)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Precision Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Precision Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Precision Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Precision Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Precision Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Precision Therapeutics Inc, Medical Equipment, Deal Details 11
Partnerships 11
Skyline Medical Plans to Form Joint Venture with CytoBioscience 11
Skyline Medical Forms Joint Venture with Helomics 12
Skyline Medical and Helomics Enter into Partnership 13
Skyline Medical Enters into Agreement with GLG Pharma 14
Equity Offering 15
Skyline Medical Raises USD2.7 Million in Public Offering of Units 15
Skyline Medical Plans to Raise up to USD2.3 Million in Public Offering of Shares 16
Skyline Medical Raises USD1.3 Million in Private Placement of Shares 17
Skyline Medical Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Units for USD4.3 Million 18
Skyline Medical Raises USD2 Million in Private Placement of Units 20
Skyline Medical Raises USD15 Million in Public Offering of Units 22
Skyline Medical Completes Private Placement Of Units For USD 2 Million 24
BioDrain Medical Completes Private Placement Of shares For USD 0.5 Million 25
BioDrain Medical Completes Private Placement Of Shares For USD 0.2 Million 26
Debt Offering 27
Skyline Medical Raises USD0.6 Million in Private Placement of Notes 27
Skyline Medical Raises USD0.1 Million in Private Placement of Notes 28
BioDrain Medical Completes Private Placement Of Convertible Notes For USD 0.3 Million 29
Acquisition 30
Precision Therapeutics Acquires 25% Stake in Helomics 30
Precision Therapeutics Inc-Key Competitors 31
Precision Therapeutics Inc-Key Employees 32
Precision Therapeutics Inc-Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Financial Announcements 34
Aug 14, 2018: Precision Therapeutics reports second quarter 2018 financial results 34
May 15, 2018: Precision Therapeutics Announces First Quarter 2018 Financial Results 36
Apr 02, 2018: Precision Therapeutics Reports Fiscal Year 2017 Financial Results 38
Nov 14, 2017: Skyline Medical Reports 2017 Third Quarter Financial Results 40
Aug 14, 2017: Skyline Medical Reports 2017 Second Quarter Financial Results 42
May 15, 2017: Skyline Medical Reports 2017 First Quarter Financial Results 44
Mar 15, 2017: Skyline Medical Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Business Update 46
Corporate Communications 48
Oct 11, 2018: Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez 48
Sep 25, 2018: Dr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, joins Precision Therapeutics Scientific Advisory Board 49
Sep 13, 2018: Precision Therapeutics appoints Dr. Paul Kornblith to Scientific Advisory Board 50
Sep 11, 2018: Precision Therapeutics names Dr. Amelia Warner to Scientific Advisory Board 51
Sep 06, 2018: Precision Therapeutics Forms Scientific Advisory Board to Advance its Strategy in the Precision Medicine Sector 52
Apr 09, 2018: Precision Therapeutics Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary 53
Legal and Regulatory 54
Aug 01, 2018: Precision Therapeutics receives approval of delisting request from German Stock Exchange 54
Jan 25, 2018: Skyline Medical Announces Corporate Name Change to Precision Therapeutics 55
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
List Of Figure
List of Figures
Precision Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Precision Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Precision Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Precision Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Precision Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Precision Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Precision Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Precision Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List Of Table
List of Tables
Precision Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Precision Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Precision Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Precision Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Precision Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Precision Therapeutics Inc, Deals By Market, 2012 to YTD 2018 9
Precision Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Skyline Medical Plans to Form Joint Venture with CytoBioscience 11
Skyline Medical Forms Joint Venture with Helomics 12
Skyline Medical and Helomics Enter into Partnership 13
Skyline Medical Enters into Agreement with GLG Pharma 14
Skyline Medical Raises USD2.7 Million in Public Offering of Units 15
Skyline Medical Plans to Raise up to USD2.3 Million in Public Offering of Shares 16
Skyline Medical Raises USD1.3 Million in Private Placement of Shares 17
Skyline Medical Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Units for USD4.3 Million 18
Skyline Medical Raises USD2 Million in Private Placement of Units 20
Skyline Medical Raises USD15 Million in Public Offering of Units 22
Skyline Medical Completes Private Placement Of Units For USD 2 Million 24
BioDrain Medical Completes Private Placement Of shares For USD 0.5 Million 25
BioDrain Medical Completes Private Placement Of Shares For USD 0.2 Million 26
Skyline Medical Raises USD0.6 Million in Private Placement of Notes 27
Skyline Medical Raises USD0.1 Million in Private Placement of Notes 28
BioDrain Medical Completes Private Placement Of Convertible Notes For USD 0.3 Million 29
Precision Therapeutics Acquires 25% Stake in Helomics 30
Precision Therapeutics Inc, Key Competitors 31
Precision Therapeutics Inc, Key Employees 32
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Precision Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Precision Therapeutics Inc (Precision Therapeutics), a joint venture between Skyline Medical and Helomics, is a medical device company. The company's business divisions include artificial intelligence to personalized medicine and drug discovery; and system for automated, direct-to-drain medical fluid disposal. Precision Therapeutics offers the STREAMWAY Fluid Waste Management system that removes surgical waste fluid from the patient using standard surgical tubing; and disposables. The company works with pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for cancer patients. It offers personalized medicine solutions for patients, clinicians and clients. Precision Therapeutics is headquartered in Eagan, Minnesota, the US.
Precision Therapeutics Inc (AIPT)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Precision Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Precision Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Precision Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Precision Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Precision Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Precision Therapeutics Inc, Medical Equipment, Deal Details 11
Partnerships 11
Skyline Medical Plans to Form Joint Venture with CytoBioscience 11
Skyline Medical Forms Joint Venture with Helomics 12
Skyline Medical and Helomics Enter into Partnership 13
Skyline Medical Enters into Agreement with GLG Pharma 14
Equity Offering 15
Skyline Medical Raises USD2.7 Million in Public Offering of Units 15
Skyline Medical Plans to Raise up to USD2.3 Million in Public Offering of Shares 16
Skyline Medical Raises USD1.3 Million in Private Placement of Shares 17
Skyline Medical Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Units for USD4.3 Million 18
Skyline Medical Raises USD2 Million in Private Placement of Units 20
Skyline Medical Raises USD15 Million in Public Offering of Units 22
Skyline Medical Completes Private Placement Of Units For USD 2 Million 24
BioDrain Medical Completes Private Placement Of shares For USD 0.5 Million 25
BioDrain Medical Completes Private Placement Of Shares For USD 0.2 Million 26
Debt Offering 27
Skyline Medical Raises USD0.6 Million in Private Placement of Notes 27
Skyline Medical Raises USD0.1 Million in Private Placement of Notes 28
BioDrain Medical Completes Private Placement Of Convertible Notes For USD 0.3 Million 29
Acquisition 30
Precision Therapeutics Acquires 25% Stake in Helomics 30
Precision Therapeutics Inc-Key Competitors 31
Precision Therapeutics Inc-Key Employees 32
Precision Therapeutics Inc-Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Financial Announcements 34
Aug 14, 2018: Precision Therapeutics reports second quarter 2018 financial results 34
May 15, 2018: Precision Therapeutics Announces First Quarter 2018 Financial Results 36
Apr 02, 2018: Precision Therapeutics Reports Fiscal Year 2017 Financial Results 38
Nov 14, 2017: Skyline Medical Reports 2017 Third Quarter Financial Results 40
Aug 14, 2017: Skyline Medical Reports 2017 Second Quarter Financial Results 42
May 15, 2017: Skyline Medical Reports 2017 First Quarter Financial Results 44
Mar 15, 2017: Skyline Medical Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Business Update 46
Corporate Communications 48
Oct 11, 2018: Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez 48
Sep 25, 2018: Dr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, joins Precision Therapeutics Scientific Advisory Board 49
Sep 13, 2018: Precision Therapeutics appoints Dr. Paul Kornblith to Scientific Advisory Board 50
Sep 11, 2018: Precision Therapeutics names Dr. Amelia Warner to Scientific Advisory Board 51
Sep 06, 2018: Precision Therapeutics Forms Scientific Advisory Board to Advance its Strategy in the Precision Medicine Sector 52
Apr 09, 2018: Precision Therapeutics Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary 53
Legal and Regulatory 54
Aug 01, 2018: Precision Therapeutics receives approval of delisting request from German Stock Exchange 54
Jan 25, 2018: Skyline Medical Announces Corporate Name Change to Precision Therapeutics 55
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
List Of Figure
List of Figures
Precision Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Precision Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Precision Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Precision Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Precision Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Precision Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Precision Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Precision Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List Of Table
List of Tables
Precision Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Precision Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Precision Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Precision Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Precision Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Precision Therapeutics Inc, Deals By Market, 2012 to YTD 2018 9
Precision Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Skyline Medical Plans to Form Joint Venture with CytoBioscience 11
Skyline Medical Forms Joint Venture with Helomics 12
Skyline Medical and Helomics Enter into Partnership 13
Skyline Medical Enters into Agreement with GLG Pharma 14
Skyline Medical Raises USD2.7 Million in Public Offering of Units 15
Skyline Medical Plans to Raise up to USD2.3 Million in Public Offering of Shares 16
Skyline Medical Raises USD1.3 Million in Private Placement of Shares 17
Skyline Medical Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Units for USD4.3 Million 18
Skyline Medical Raises USD2 Million in Private Placement of Units 20
Skyline Medical Raises USD15 Million in Public Offering of Units 22
Skyline Medical Completes Private Placement Of Units For USD 2 Million 24
BioDrain Medical Completes Private Placement Of shares For USD 0.5 Million 25
BioDrain Medical Completes Private Placement Of Shares For USD 0.2 Million 26
Skyline Medical Raises USD0.6 Million in Private Placement of Notes 27
Skyline Medical Raises USD0.1 Million in Private Placement of Notes 28
BioDrain Medical Completes Private Placement Of Convertible Notes For USD 0.3 Million 29
Precision Therapeutics Acquires 25% Stake in Helomics 30
Precision Therapeutics Inc, Key Competitors 31
Precision Therapeutics Inc, Key Employees 32
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Precision Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 179 | 
February 2020
Page 116 | January 2020
Page 235 | January 2020
Page 183 | September 2019
Page 244 | August 2019